Testing effectiveness (Phase 2)Ended earlyNCT02506114What this trial is testingNeoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate CancerWho this might be right forProstatic Neoplasms Lawrence Fong 15
Not applicableLooking for participantsNCT01050504What this trial is testingCollecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerWho this might be right forLocalized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more University of Washington 1,500
Early research (Phase 1)Study completedNCT03237416What this trial is testingDrug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male VolunteersWho this might be right forProstatic Neoplasms Bayer 15
Testing effectiveness (Phase 2)Looking for participantsNCT05125016What this trial is testingA Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer Regeneron Pharmaceuticals 228
Not applicableLooking for participantsNCT06940271What this trial is testingFeasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During ProstatectomyWho this might be right forLocalized Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more Mayo Clinic 45
Testing effectiveness (Phase 2)Study completedNCT06395753What this trial is testingA Dose Finding Study of Debio 4228 in Participants With Advanced Prostate CancerWho this might be right forProstate Cancer Debiopharm International SA 55
Not applicableEnrolling By InvitationNCT06604130What this trial is testingPlasma Exosome RNA to Diagnose Prostate CancerWho this might be right forProstate Cancer Xijing Hospital 1,600
Not applicableLooking for participantsNCT06274892What this trial is testingRemote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review ProcessWho this might be right forProstate CancerBreast Cancer University Health Network, Toronto 124
Large-scale testing (Phase 3)Study completedNCT00233610What this trial is testingTwo Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate CancerWho this might be right forProstate Cancer AstraZeneca 180
Not applicableStudy completedNCT05294627What this trial is testingValidation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss PopulationWho this might be right forProstate CancerLocalized Carcinoma University Hospital, Basel, Switzerland 380
Early research (Phase 1)Ended earlyNCT00848601What this trial is testingSafety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's LymphomaWho this might be right forProstate CancerNon-Hodgkins Lymphoma Astex Pharmaceuticals, Inc. 14
Testing effectiveness (Phase 2)Ended earlyNCT04171700What this trial is testingEvaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesWho this might be right forSolid Tumor pharmaand GmbH 83
Testing effectiveness (Phase 2)Ended earlyNCT03837353What this trial is testingA Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1Who this might be right forProstate Cancer NYU Langone Health 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783153What this trial is testingEfficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer PatientsWho this might be right forRadiotherapy Induced DiarrheaAcute Radiation EnteritisProstate Cancer+5 more Mansoura University 80
Not applicableStudy completedNCT05181800What this trial is testingFIRMAGON® Intensive Drug MonitoringWho this might be right forProstate Cancer Ferring Pharmaceuticals 1,454
Not applicableLooking for participantsNCT05926102What this trial is testingThe Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)Who this might be right forProstate Cancer VA Office of Research and Development 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06402331What this trial is testingFPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)Who this might be right forMetastatic Castration-resistant Prostate Cancer Fusion Pharmaceuticals Inc. 110
Early research (Phase 1)Looking for participantsNCT07149831What this trial is testingA Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese AdultsWho this might be right forProstate Cancer Sinotau Pharmaceutical Group 6
Not applicableStudy completedNCT02963675What this trial is testingIncidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in SwedenWho this might be right forProstatic Neoplasms Bayer 15,953
Early research (Phase 1)Study completedNCT01574937What this trial is testingXL-184+Abiraterone in Post-Chemo CRPCWho this might be right forProstate Cancer Dana-Farber Cancer Institute 27